Empagliflozin in Early Diabetic Kidney Disease

Trial Profile

Empagliflozin in Early Diabetic Kidney Disease

Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Dec 2017

At a glance

  • Drugs Empagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2017 Planned initiation date changed from 6 Dec 2017 to 15 Dec 2017.
    • 25 Nov 2017 Planned initiation date changed from 27 Nov 2017 to 6 Dec 2017.
    • 21 Nov 2017 Planned initiation date changed from 1 Nov 2017 to 27 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top